# Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

> **NCT03705351** · PHASE1 · TERMINATED · sponsor: **Providence Health & Services** · enrollment: 7 (actual)

## Conditions studied

- Glioblastoma
- Cancer of Brain
- Glioblastoma Multiforme
- Brain Tumor

## Interventions

- **DEVICE:** Tumor Treating Fields
- **DRUG:** Temozolomide
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT03705351
- **Lead sponsor:** Providence Health & Services
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-02
- **Primary completion:** 2021-02-24
- **Final completion:** 2022-02-24
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Prinicipal Investigator departure from institution
- **Last updated:** 2024-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03705351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03705351, "Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03705351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*